Comorbidities, Sphincterotomy, and Balloon Dilation Predict Post-ERCP Adverse Events in PSC Patients: Operator Experience Is Protective

被引:42
作者
Alkhatib, Amer A. [1 ]
Hilden, Kristen [1 ]
Adler, Douglas G. [1 ]
机构
[1] Univ Utah, Sch Med, Huntsman Canc Ctr, Salt Lake City, UT 84132 USA
关键词
Cholangitis; primary sclerosing; Cholangiopancreatoscopy; endoscopic retrograde; Pancreatitis; Sphincterotomy; endoscopic; PRIMARY SCLEROSING CHOLANGITIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; RISK-FACTORS; COMPLICATIONS; THERAPY; STRICTURES;
D O I
10.1007/s10620-011-1830-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease. Interventional ERCP improves survival in PSC patients. To describe the frequency and risk factors for post-ERCP adverse events in patients with PSC via multivariate analysis. Retrospective cohort study included patients with a diagnosis of PSC who underwent ERCP at academic institutions between February 2000 and October 2009. Demographis, co-morbid conditions, antibiotic use, cannulation method, ERCP maneuvers and 30-day post-ERCP adverse events were collected. Multivariate analysis was performed using logistic regression. A total of 185 procedures were performed on 75 PSC patients (58 M,17 F). Seven endoscopists performed ERCPs. Comorbidies included ulcerative colitis (44%, n = 33), Crohn's disease (12%, n = 9 patients), Cirrhosis (8%, n = 6 patients) and autoimmune hepatitis (2.7%, n = 2). Cannulation was achieved using dye-free guidewire cannulation techniques in 139/185 procedures (76%) and with contrast-based techniques in 46/185 procedures (24%). Thirty-day post-ERCP adverse events included post-ERCP pancreatitis (5%, n = 9, cholangitis (1%, n = 2), acute cholecystitis (0.5%, n = 1), stent occlusion (0.5%, n = 1), stent migration (0.5%, n = 1), and bile leak (0.5%, n = 1). In the multivariate analysis, associations with specific endoscopists who performed the procedure (P = 0.01), biliary dilation (P = 0.02), sphincterotomy (P = 0.03), presence of cirrhosis (P = 0.05), Crohn's disease (P < 0.001), and autoimmune hepatitis (P < 0.001) significantly predicted a complication following ERCP. Gender, stenting during procedure, presence of a dominant stricture, and cholangitis were not predictive for post-ERCP adverse events. Factors predicting 30-day post-ERCP adverse events included certain co-morbid conditions, the endoscopist ERCP volume, maneuvers during ERCP including dilation and sphincterotomy. Stenting was not associated with adverse events.
引用
收藏
页码:3685 / 3688
页数:4
相关论文
共 13 条
[1]   Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis [J].
Baluyut, AR ;
Sherman, S ;
Lehman, GA ;
Hoen, H ;
Chalasani, N .
GASTROINTESTINAL ENDOSCOPY, 2001, 53 (03) :308-312
[2]   Complications of Endoscopic Retrograde Cholangiopancreatography in Primary Sclerosing Cholangitis [J].
Bangarulingam, Sanjay Y. ;
Gossard, Andrea A. ;
Petersen, Bret T. ;
Ott, Beverly J. ;
Lindor, Keith D. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (04) :855-860
[3]  
BILBAO MK, 1976, GASTROENTEROLOGY, V70, P314
[4]   Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis [J].
deWit, AWMV ;
vanBracht, J ;
Rauws, EAJ ;
Jones, EA ;
Tytgat, GNJ ;
Huibregtse, K .
GASTROINTESTINAL ENDOSCOPY, 1996, 44 (03) :293-299
[5]   Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography [J].
Enns, R ;
Eloubeidi, MA ;
Mergener, K ;
Jowell, PS ;
Branch, MS ;
Baillie, J .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 17 (04) :243-248
[6]   Complications after ERCP in patients with primary sclerosing cholangitis [J].
Etzel, Jason P. ;
Eng, Sue C. ;
Ko, Cynthia W. ;
Lee, Scott D. ;
Saunders, Michael D. ;
Tung, Bruce Y. ;
Kimmey, Michael B. ;
Kowdley, Kris V. .
GASTROINTESTINAL ENDOSCOPY, 2008, 67 (04) :643-648
[7]   Risk factors for post-ERCP pancreatitis: a prospective, multicenter study [J].
Freeman, ML ;
DiSario, JA ;
Nelson, DB ;
Fennerty, MB ;
Lee, JG ;
Bjorkman, DJ ;
Overby, CS ;
Aas, J ;
Ryan, ME ;
Bochna, GS ;
Shaw, MJ ;
Snady, HW ;
Erickson, RV ;
Moore, JP ;
Roel, JP .
GASTROINTESTINAL ENDOSCOPY, 2001, 54 (04) :425-434
[8]   A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis [J].
Gluck, Michael ;
Cantone, Nico R. ;
Brandabur, John J. ;
Patterson, David J. ;
Bredfeldt, James E. ;
Kozarek, Richard A. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2008, 42 (09) :1032-1039
[9]  
Kaya M, 2001, AM J GASTROENTEROL, V96, P1059
[10]  
Silviera ML, 2009, J GASTROINTEST LIVER, V18, P73